Project Grant HT94252410479
Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $5.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
- The University of Washington received a $310,697 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on the use of noninvasive focused ultrasound stimulation of the hypoglossal nerve to treat obstructive sleep apnea. The two-year grant period runs from February 1, 2024 to January 31, 2026. As part of the grant, the University of Washington will investigate this novel treatment approach aimed at improving outcomes...
- The Department of the Army Medical Command awarded a $5.95 million cooperative agreement to The Johns Hopkins University on September 30, 2022 under the Military Medical Research and Development program (CFDA 12.420). The four-year award will fund a randomized controlled trial to evaluate cognitive-behavioral therapy versus mindfulness-based treatment for insomnia and post-traumatic stress symptoms related to traumatic brain injury. Sub-awards were provided to The Henry M. Jackson Foundation For...
- Federal Project Grant Award Summary The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. received a $1.94 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to increase access to evidence-based behavioral health treatments for insomnia in the Military Health System. The award was obligated on September 1, 2025, with an ultimate completion date of August 31, 2029. This four-year initiative...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $4.98 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded October 1, 2025, with completion targeted for September 30, 2029. The research initiative, "Light Therapy to Improve Sleep in Veterans with TBI: Sleep-Active Biomarkers and Glymphatic Function," focuses on developing and evaluating light therapy interventions...
- This $2,301,698 project grant awarded on September 30, 2023 by the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports the "Virtual Insomnia Patients (VIPS) to Accelerate Dissemination of Precision Diagnosis and Treatment of Insomnia" research project. The prime awardee, Arizona State University, will collaborate with sub-awardees including the University of Texas Health Science Center at San Antonio, University of North Texas, and the...
- The Department of the Army Medical Command awarded a $384,001 Project Grant to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2022 to February 29, 2024 to investigate the neural circuit mechanisms of stress-induced insomnia and metabolic dysfunction. Through its support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
- The U.S. Department of the Army Medical Command awarded a $1,277,097 Project Grant to Oregon Health & Science University (OHSU) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE," aims to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The project will run from Sep...
- Federal Grant Award Summary HMH Hospitals Corporation, doing business as Hackensack University Medical Center, received a $4.36 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2025, through September 29, 2029. The award funds a clinical trial designed to evaluate the efficacy of Building Emotional Self-Awareness (BESA) teletherapy in improving psychological health outcomes for...
- The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
- The University of Maryland, College Park will receive $712,011 through a three-year Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support modeling and cross-sectional analysis of movement quality for service members using osseointegrated prostheses. Through June 2026, the University will conduct research to transform health care and investigate medical solutions for the battlefield....